This inventor holds 5 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Black Diamond Therapeutics, Inc., Bright Peak Therapeutics Ag, Monte Rosa Therapeutics Ag. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 4 
1 out of 4 
1 out of 3 Years Active: 2024-2026
Title: Alexander Flohr: Innovator in Pharmaceutical Compounds
Introduction
Alexander Flohr is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating abnormal cell growth.
Latest Patents
Flohr holds three patents, with his latest innovations focusing on alkynyl quinazoline compounds and isoindolinone compounds. The alkynyl quinazoline compounds relate to methods of preparation and their use in preventing or treating abnormal cell growth in mammals, especially humans. The isoindolinone compounds are disclosed as modulators of cereblon, with various applications in the treatment of abnormal cell growth.
Career Highlights
Throughout his career, Flohr has worked with prominent companies in the pharmaceutical industry, including Monte Rosa Therapeutics, Inc. and Monte Rosa Therapeutics AG. His work has been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Flohr has collaborated with notable professionals in his field, including Bernhard Fasching and Thomas Ryckmans. These collaborations have further enhanced his contributions to pharmaceutical innovations.
Conclusion
Alexander Flohr's work in developing novel pharmaceutical compounds showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile